2025 Annual Report Vistin Pharma ASA

Oslo, Norway, 24 April 2026

Please find attached the Annual Report for 2025 for Vistin Pharma ASA (VISTN). There is no material changes in the financial statement compared to the preliminary full year result presented on 12 February 2026.

The annual report for 2025 will also be made available on www.vistin.com.

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
[email protected]

Attachments

• Annual Report 2025 Vistin Pharma ASA_final
• Vistinpharmaasa-2025-12-31-1-en

You May Also Be Interested In

• Partners Value Investments Inc. Announces Q2 2026 Interim Results
• American Fusion Inc. (OTC: AMFN) Engages Lucosky Brookman LLP as Securities and Capital Markets Counsel for Planned National Exchange Uplisting
• Adaptogenics Health Corp. Announces Non-Brokered Private Placement